Beyond the Headlines, Columns-Drugs & Supplements, September 2005
September 22, 2005
FDA Approves Genetic Test for Drug Therapy Safety WASHINGTON, D.C. - A new blood test that will help doctors make personalized drug treatment decisions was approved by the Food and Drug Administration on Aug. 22. Third Wave Technologies' Invader UGT1A1 Molecular Assay detects variations in a gene that affects how certain drugs are broken down and cleared by the body, the FDA said, noting that doctors can use this information to help determine the right drug dosage for individual patients and minimize harmful drug reactions. Invader detects variations in the UGT1A1 gene that produces the …
UPCOMING CONFERENCES
HarrisMartin’s Artificial Stone Silicosis Epidemic Litigation ConferenceJanuary 10, 2025 - Long Beach, CA
The Westin Long Beach
|
